Skip to main content
Skip to content
Case File
efta-01522167DOJ Data Set 10Other

EFTA01522167

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01522167
Pages
1
Persons
0
Integrity

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
GHISLAINE MAXWELL- OAP FDG ACC For the Period 3/1/12•1. Equity Summary Asset Categories US Large Cap Eguky Beginning Ending Change Current Market Value Market Value In Value Allocation 163,689.55 167,788.39 4,098.84 96% Market Value/Cost Current Penod Value Market Value 167,788.39 Tax Cost 144,990.02 Unrealized Gain/Loss 22,798.37 Estimated Annual Income 5,465.67 Accrued Dividends 108.93 Yield 3.25% Equity Detail Adjusted Tax Cost Unrealized Est. Annual Inc. Price Quantity Value Original Cost Gain/Loss Accrued Div. Yield US Large Cap Equity ABBOTT LABORATORIES 002824-10-0 ABT 61.29 148.000 9,070.92 7,308.74 1,762.18 301.92 3.33% ANALOG DEVICES INC 032654-10-5 ADI 40.40 176.000 7,110.40 6,011.39 1,099.01 211.20 2.97% AUTOMATIC DATA PROCESSING INC 053015-10.3 ADP 55.19 150.000 8278.50 7.264.05 1,014.45 237.00 59.25 2.86% JP Morgan Page 4 of 11 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00049659 SDNY_GM_00318857 EFTA01522167

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.